Timetable

  Thursday, October 17, 2019

  Hall A  Meeting Room 1/2
 08:00 – 16:20 Ultrasound Workshop
Supported by Novartis
 16:20 – 16:30 Break
 16:30 – 17:00 Opening Session  
17:00 – 17:10 Break
17:10 – 18:10 Industry Symposium:
Re-assessing the ESCEO algorithm for knee OA in the long-term perspective
Supported by Mylan
 
18:10 Networking Reception

 

  Friday, October 18, 2019

  Hall A
 07:45 – 08:45 Round Table:
Headache for rheumatologists: Arthritis pain and central sensitization syndrome
 08:45 – 09:45 Round Table:
Osteoporosis in rheumatic diseases: A neglected story in rheumatology

 09:45 – 10:05 Coffee Break and Poster Viewing
 10:05 – 11:05 Debate:
Biosimilars or Janus Kinase inhibitors (JAKi) should be the first line treatment of rheumatoid arthritis?

 11:05 – 12:05 APLAR Session:
Novel approaches for osteoarthritis outcome prediction

12:05 – 12:20 Lunch Break and Poster Viewing
12:20 – 13:20 Industry Symposium:
Expansion of treatment options in RA

Supported by Celltrion
13:20 – 14:20 Round Table:
Which biologics are safe for tuberculosis and/or hepatitis C?

14:20 – 15:20 Debate:
Intraarticular injections of platelet rich plasma for osteoarthritis treatment: What to tell the patient

15:20 – 15:40 Coffee Break and Poster Viewing
15:40 – 16:40 Round Table:
Systemic lupus erythematosus: Biologic or non-biologic treatment?
16:40 – 17:40 Taiwan Rheumatology Association Symposium:
Biosimilars in rheumatology: Perspectives around the world
17:40 – 18:30 Poster Session and Refreshments

 

  Saturday, October 19, 2019

  Hall A
 08:00 – 09:00 Consensus:
Cardiovascular risks in inflammatory arthritis: Risk assessment and management in daily practice

09:00 – 09:45 Session:
Oral Abstract Presentations

 09:45 – 10:00 Coffee Break and Poster Viewing
10:00 – 11:00 Round Table:
Lessons learned from the registries: Did it change practice?

11:00 – 12:00 Industry Symposium:
The many faces of Janus Kinase inhibitors in rheumatology
Supported by Pfizer
12:00 – 13:00 Lunch Break and Poster Viewing
13:00 – 14:30 Round Table:
Large vessel vasculitis: What are the options for investigation, disease treatment and management?
14:30 – 14:45 Coffee Break and Poster Viewing
14:45 – 15:45 Debate:
Gout and crystal arthropathies: Benign diseases with a potentially deadly outcome?
15:45 – 16:45 Round Table:
The future of rheumatology: Reality and challenges

16:45 – 16:50 Closing Remarks

*Subject to change